Cosmecca Korea Co., Ltd.

Cosmecca Korea Co., Ltd.

Cosmecca Korea Co., Ltd.

Overview
Date Founded

1999

Headquarters

17-12 Daegeum-ro 196beon-gil,Daeso-myeon,Eumseong-gun, North Chungcheong 27670

Type of Company

Public

Employees (Worldwide)

560

Industries

Personal Products

Company Description

Cosmecca Korea Co., Ltd. is engaged in the manufacturing of perfumes and cosmetics. It offers product design, manufacturing, packaging, storage and shipment of cosmetics. The company was founded on October 5, 1999 and is headquartered in Eumseong, South Korea.

Executives & Employees

President & Chief Executive Officer

Co-Chief Executive Officer & Director

Senior Managing Director & Head-China Sales

Director & Vice President

Board of Directors

President & Chief Executive Officer at Cosmecca Korea Co., Ltd.

Co-Chief Executive Officer & Director at Cosmecca Korea Co., Ltd.

Director & Vice President at Cosmecca Korea Co., Ltd.

Independent Director at Cosmecca Korea Co., Ltd.

Independent Director at Cosmecca Korea Co., Ltd.

Paths to Cosmecca Korea Co., Ltd.
Potential Connections via
Relationship Science
You
Cosmecca Korea Co., Ltd.
Recent Transactions
Details Hidden

Cosmecca Korea Co., Ltd. purchases Englewood Lab, Inc.

Transaction Advisors
Investment Advisor

Advised onCosmecca Korea Co., Ltd. purchases Englewood Lab, Inc.

Clients

VT GMP Co., Ltd. engages in the manufacture and sale of laminating films and laminating machines. It operates through following business divisions: Machinery, Film, and Cosmetics. The machinery business division offers products such as bearing, heater, roller, wire motor, and others. The Film business division offers products such as Time Capsule, Pronex, Crystalex, and Micronex overlay Coating Films. The cosmetics business division offers cosmetic merchandises. The company was founded on November 15, 1986 and is headquartered in Paju-si, South Korea.

TONYMOLY Co., Ltd. engages in the manufacture and sale of cosmetics and skin care products. It markets beauty and personal care products such as lotion, emulsion, essence, ample, serum, cream, eye care, sun care, mist, booster, special products; cleansing foam, cleansing cream, cleansing gel, oil, tissue, and others. The company was founded by Hae-Dong Bae on July 26, 2006 and is headquartered in Seoul, South Korea.

CLIO Cosmetics Co., Ltd. engages in the manufacture and sale of cosmetics. Its products include skin care basic, point make ups, base make up, and others. The company was founded on May 31, 1997 and is headquartered in Seoul, South Korea.

Key Stats and Financials As of 2019
Market Capitalization
$119M
Total Enterprise Value
$235M
Earnings Per Share
$0.41
EBITDAMargin
7.06%
Enterprise Value / Sales
0.76x
Enterprise Value EBITDAOperating
10.7x
TEVNet Income
53.88x
Debt TEV
0.43x
Three Year Compounded Annual Growth Rate Of Revenue
28.08%
Five Year Compounded Annual Growth Rate Of Revenue
38.41%
Revenue
$311M
Net Profit
$4.36M
EBITDA
$22M
Total Debt
$101M
Total Equity
$155M
Suppliers
Kolon Life Science, Inc. Biotechnology | Seoul, South Korea

Kolon Life Science was established in January 2006 by integrating the businesses in the areas of Active Pharmaceutical Ingredients and Eco-friendly Chemicals with its core business in Biological New Drug, previously covered within Kolon Group as the business of the future. We have not only proved our technological power as a bioindustry, but also created a new business model for a bioscience company that works on a stable, sales-based foundation. For the businesses in Active Pharmaceutical Ingredients and Eco-friendly Chemicals that form the basis for our stable sales, we are putting our efforts to expand our local market as well as to establish our foothold in overseas markets, by launching new products through continuous investments in R&D. Tissuegene-C, a new drug for arthritis therapy, for instance, was developed by our Biological New Drug business, which will be our major driving force in the future. The Phase-II Clinical Trial was already approved by KFDA in 2009 and subsequent trials will be conducted. We have already built a pipeline of drugs for cell-mediated gene therapy for the treatment of various diseases, including stroke, as well as for protein therapy for rheumatic arthritis, Parkinson’s disease, and etc. We will continue to build the pipeline to expand our business in Biological New Drug as the core business of the company. While Kolon Life Science is dedicated to become a global leader in bioscience, our efforts can only be rewarded by your continuous interest and support for Kolon Life Science Thank you again for visiting our homepage.

HYUNDAI BIOLAND Co., Ltd. Personal Products | Cheonan, South Korea

HYUNDAI BIOLAND Co., Ltd. engages in the manufacture and sale of pharmaceutical and functional products. It operates through the following business divisions: Cosmetics Ingredients, Functional Food Ingredients, Active Pharmaceuticals Ingredients, and Biomedical Devices. The Cosmetics Ingredients divison supplies non-toxic and non-stimulus ingredients. The Functional Food Ingredients division offers natural resources for health such as to skin moisturization, bone, immune system, and fatigue recovery. The Biomedical Devices supplies soft and hard tissues with cutting-edge fusion technology. The company was founded on September 1, 1995 and is headquartered in Cheonan-si, South Korea.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cosmecca Korea Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cosmecca Korea Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cosmecca Korea Co., Ltd..